BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9597195)

  • 1. Hyperhomocysteinaemia and vascular disease.
    Townend J; O'Sullivan J; Wilde JT
    Blood Rev; 1998 Mar; 12(1):23-34. PubMed ID: 9597195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia.
    Harmon DL; Woodside JV; Yarnell JW; McMaster D; Young IS; McCrum EE; Gey KF; Whitehead AS; Evans AE
    QJM; 1996 Aug; 89(8):571-7. PubMed ID: 8935478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinaemia and associated disease.
    Bakker RC; Brandjes DP
    Pharm World Sci; 1997 Jun; 19(3):126-32. PubMed ID: 9259028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of hyperhomocysteinaemia in cardiovascular disease.
    Lievers KJ; Kluijtmans LA; Blom HJ
    Ann Clin Biochem; 2003 Jan; 40(Pt 1):46-59. PubMed ID: 12542910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease.
    Boers GH
    Neth J Med; 1994 Jul; 45(1):34-41. PubMed ID: 8065483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?
    den Heijer M; Blom HJ; Gerrits WB; Rosendaal FR; Haak HL; Wijermans PW; Bos GM
    Lancet; 1995 Apr; 345(8954):882-5. PubMed ID: 7707810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteinemia: new information about an old risk factor for vascular disease.
    Engman M
    J Insur Med; 1998; 30(4):231-6. PubMed ID: 10537928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia: a risk factor for arterial and venous thrombotic disease.
    Cattaneo M
    Int J Clin Lab Res; 1997; 27(3):139-44. PubMed ID: 9352375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic determinants of hyperhomocysteinaemia: the roles of cystathionine beta-synthase and 5,10-methylenetetrahydrofolate reductase.
    Blom HJ
    Eur J Pediatr; 2000 Dec; 159 Suppl 3():S208-12. PubMed ID: 11216902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance.
    Boers GH
    Thromb Haemost; 1997 Jul; 78(1):520-2. PubMed ID: 9198207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: an independent risk factor for vascular disease.
    McKinley MC
    Proc Nutr Soc; 2000 May; 59(2):221-37. PubMed ID: 10946791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate hyperhomocysteinaemia and vascular disease: evidence, relevance and the effect of treatment.
    Boers G
    Eur J Pediatr; 1998 Apr; 157 Suppl 2():S127-30. PubMed ID: 9587040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine and vascular disease.
    Berwanger CS; Jeremy JY; Stansby G
    Br J Surg; 1995 Jun; 82(6):726-31. PubMed ID: 7627498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High plasma homocysteine: a risk factor for vascular disease in the elderly.
    Moustapha A; Robinson K
    Coron Artery Dis; 1998; 9(11):725-30. PubMed ID: 9919419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common C677T polymorphism in the methylenetetrahydrofolate reductase gene increases the risk for deep vein thrombosis in patients with predisposition of thrombophilia.
    Fujimura H; Kawasaki T; Sakata T; Ariyoshi H; Kato H; Monden M; Miyata T
    Thromb Res; 2000 Apr; 98(1):1-8. PubMed ID: 10706928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial hyperhomocysteinaemia and endothelium-dependent vasodilatation and arterial distensibility of large arteries.
    Lambert J; van den Berg M; Steyn M; Rauwerda JA; Donker AJ; Stehouwer CD
    Cardiovasc Res; 1999 Jun; 42(3):743-51. PubMed ID: 10533615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinaemia as a cardiovascular risk factor: an update.
    van der Griend R; Biesma DH; Banga JD
    Neth J Med; 2000 Mar; 56(3):119-30. PubMed ID: 10759023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutated 5,10-methylenetetrahydrofolate reductase and moderate hyperhomocysteinaemia.
    Blom HJ
    Eur J Pediatr; 1998 Apr; 157 Suppl 2():S131-4. PubMed ID: 9587041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocystinuria: what about mild hyperhomocysteinaemia?
    van den Berg M; Boers GH
    Postgrad Med J; 1996 Sep; 72(851):513-8. PubMed ID: 8949585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.
    Robinson K; Arheart K; Refsum H; Brattström L; Boers G; Ueland P; Rubba P; Palma-Reis R; Meleady R; Daly L; Witteman J; Graham I
    Circulation; 1998 Feb; 97(5):437-43. PubMed ID: 9490237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.